Neonatal mesenchymal stem cell treatment improves myelination impaired by global perinatal asphyxia in rats
dc.contributor.author | Tapia-bustos, A. | |
dc.contributor.author | Lespay-rebolledo, C. | |
dc.contributor.author | Vío, V. | |
dc.contributor.author | Pérez-lobos, R. | |
dc.contributor.author | Casanova-ortiz, E. | |
dc.contributor.author | Ezquer, F. | |
dc.contributor.author | Herrera-marschitz, M. | |
dc.contributor.author | Morales, P. | |
dc.date.accessioned | 2021-05-25T22:33:04Z | |
dc.date.available | 2021-05-25T22:33:04Z | |
dc.date.issued | 2021-03 | |
dc.description | Indexación Scopus | es |
dc.description.abstract | The effect of perinatal asphyxia (PA) on oligodendrocyte (OL), neuroinflammation, and cell viability was evaluated in telencephalon of rats at postnatal day (P)1, 7, and 14, a period char-acterized by a spur of neuronal networking, evaluating the effect of mesenchymal stem cell (MSCs)- treatment. The issue was investigated with a rat model of global PA, mimicking a clinical risk oc-curring under labor. PA was induced by immersing fetus-containing uterine horns into a water bath for 21 min (AS), using sibling-caesarean-delivered fetuses (CS) as controls. Two hours after delivery, AS and CS neonates were injected with either 5 μL of vehicle (10% plasma) or 5 × 104 MSCs into the lateral ventricle. Samples were assayed for myelin-basic protein (MBP) levels; Olig-1/Olig-2 tran-scriptional factors; Gglial phenotype; neuroinflammation, and delayed cell death. The main effects were observed at P7, including: (i) A decrease of MBP-immunoreactivity in external capsule, corpus callosum, cingulum, but not in fimbriae of hippocampus; (ii) an increase of Olig-1-mRNA levels; (iii) an increase of IL-6-mRNA, but not in protein levels; (iv) an increase in cell death, including OLs; and (v) MSCs treatment prevented the effect of PA on myelination, OLs number, and cell death. The present findings show that PA induces regional- and developmental-dependent changes on myelination and OLs maturation. Neonatal MSCs treatment improves survival of mature OLs and myelination in telencephalic white matter. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | es |
dc.description.uri | https://www.mdpi.com/1422-0067/22/6/3275 | |
dc.identifier.citation | International Journal of Molecular Sciences, Volume 22, Issue 6, 2 March 2021, Article number 3275 | es |
dc.identifier.doi | 10.3390/ijms22063275 | |
dc.identifier.issn | 16616596 | |
dc.identifier.uri | http://repositorio.unab.cl/xmlui/handle/ria/18947 | |
dc.language.iso | en | es |
dc.publisher | MDPI AG | es |
dc.subject | Remyelinization | es |
dc.subject | Oligodendrocyte Precursor Cells | es |
dc.subject | Cuprizone | es |
dc.subject | Mesenchymal stem cells | es |
dc.subject | Neonatal asphyxia/ischemia | es |
dc.subject | Periventricular leukomalacia | es |
dc.title | Neonatal mesenchymal stem cell treatment improves myelination impaired by global perinatal asphyxia in rats | es |
dc.type | Artículo | es |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Tapia_A_Neonatal_mesenchymal_2021.pdf
- Tamaño:
- 6.43 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- TEXTO COMPLETO EN INGLÉS
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: